- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
FINANCIALS
4:56pm
PHARMACEUTICALS
4:52pm
Genus plans further China expansion
Animal genetics group eyes joint ventures in pork farming
PHARMACEUTICALS
2:37pm
Elan chief tests faith over future
Little clarity over how company will be moulded
PHARMACEUTICALS
10:28am
Royalty Pharma in $6.6bn bid for Elan
Investment group eyes future income from multiple sclerosis drug
©Reuters
PHARMACEUTICALS
9:09pm
Novartis’ U-turn marks a crossroads
Retirement package for Vasella raises investor scrutiny over pay
PHARMACEUTICALS
Feb 23, 2013
Elan unveils share $1bn buyback
Drug group’s plan includes move to seek fresh acquisitions
HEALTH CARE
Feb 23, 2013
Surgical Innovations looks to US sales
Company secures regulatory approval for its PretzelFlex instrument
From
MARKETS
Feb 23, 2013
Phytopharm falls after drug test failure
Trial for Parkinson’s treatment shows drug has no effects
©Reuters
PHARMACEUTICALS
Feb 22, 2013
Vasella admits mistakes over $78m payout
Shareholders not appeased by Novartis chairman’s concession
From
WORLD
Feb 20, 2013
Pryce faces retrial after jury discharged
Circumstances of case raise questions about jury system
From
TECHNOLOGY
Feb 20, 2013
Winners of life science prize revealed
Silicon Valley billionaires pledge $50m
PHARMACEUTICALS
Feb 19, 2013
Novartis pay criticism unlikely to abate
The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack
From
MARKETS
Feb 19, 2013
Developing world boost for GM crops
Global planted area rises by 6 per cent to 170m hectares
PHARMACEUTICALS
Feb 19, 2013
Novartis scraps chairman’s $78m payout
Shareholder anger forces U-turn on Vasella
PHARMACEUTICALS
Feb 18, 2013
Novartis chairman’s pay-off sparks anger
Vasella to be given SFr72m ‘golden goodbye’ for confidentiality
From
WORLD
Feb 18, 2013
Suffering side-effects of health reform
Critics see threat to Obamacare goals
From
WORLD
Feb 18, 2013
US business hits out at ‘Obamacare’ costs
Employers may cut hours or pay fines to avoid insurance
Multimedia
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
business blog
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
Chief Executive, Shareholder Executive
BIS
-
VP EUROPEAN SALES
Manufacturing
-
Senior Analyst, NA Gas Infrastructure Pipeline
Wood Mackenzie
-
Chief Financial Officer
Marine Transportation Industry
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Elan / Royalty Pharma: gone shopping
Which investment banker-turned-pharma executive will investors choose to back?